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Summary
Conclusion: The clinical significance of intrapancreatic accessory spleens resides in the mimicry of
pancreatic cancer. Radionuclide tests (Octreotide scan and Tc99m sulfur colloid scan) should be under-
taken to distinguish these lesions from neuroendocrine tumors, hypervascular metastases and pan-
creatic carcinoma. If the tests are equivocal, diagnostic laparotomy or laparoscopy is recommended.
Background: Despite its relatively common occurrence, intrapancreatic ectopic splenic tissue is rarely
detected owing to its asymptomatic nature.
Methods: We report a case of a clinically asymptomatic patient in which abdominal computed tomog-
raphy (CT) scans revealed a mass of 1.5 cm in diameter in the distal pancreas. The tumor markers CA 19-9
and carcinoembryonic antigen (CEA) were slightly elevated, and pancreatic neoplasm was suspected.
Results: Left pancreatic resection and splenectomy were performed. The removed specimen disclosed
the presence of an accessory spleen within the pancreatic tail.
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Introduction
Ectopic splenic tissue in the abdominal cavity is
a common entity, with a reported incidence of 10%
in the general population (1), and can be separated
into two categories: splenosis resulting from auto-
transplantation of splenic tissue, usually after
splenectomy; and accessory spleens, which are con-
genital duplications of splenic tissue in an ectopic
location. Intrapancreatic location was found in about
16% of cases in autopsy series (2), but it is rarely
detected in clinical practice owing to a lack of symp-
toms. In contrast, the frequency of detected pancre-
atic mass on computed tomography (CT) scan is
rising, and therefore, accessory spleen within the
pancreas can be an important differential diagnosis
in these patients. In this article, we describe a patient
with accessory spleen in the tail of the pancreas
where a pancreatic neoplasm was suspected initially.
Treatment consisted of a left pancreatic resection.
Case Report
A 71-yr-old man was hospitalized in the derma-
tology department for exploration of a leukocyto-
clastic vasculitis. He had a known history of ethanol
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abuse of up to 1.5 L of beer/d and a nicotine abuse
of 6 yr. During this stay, arterial hypertension was
detected. Further investigations revealed an
infrarenal aortic aneurysm of 4 cm in diameter and
a significant stenosis of the right renal artery. In addi-
tion, an abdominal CT scan delineated a hypervas-
cular, enhancing tumor formation of 1.5 cm in
diameter in the pancreatic tail (Fig. 1). CT-controlled
fine-needle aspiration failed because of the patient’s
lack of compliance. Therefore, he was referred to
our department for surgical exploration.
On admission, he had no complaints, a normal
nutritional status, and no jaundice. The abdomen
was not tender to pressure, and no resistance or mass
was palpable. With the exception of a raised ery-
throcyte sedimentation rate of 57 mm/h (normal: 20
mm/h), a creatinine value of 119 mol/L(normal range
59–116 mol/L), and an unspecific dysproteinemia,
blood sample analyses were unremarkable. The
tumor markers CA 19-9 and carcinoembryonic
antigen (CEA) were slightly elevated with values of
27.2 kU/L (normal: <22 kU/L) and 3.1 mol/L,
respectively (normal <1.5 mol/L); also, determina-
tion of the gastrointestinal hormones revealed no
abnormal values. Endoscopic retrograde cholan-
giopancreaticography (ERCP) showed an unre-
markable common bile duct and a normal-appearing
pancreatic duct with regular side branches. At
laparotomy, exploration of the pancreas demon-
strated a normal head and body with an enlarged tail
region of inconspicuous consistency. Based on the
CT findings, a left pancreatic resection and splenec-
tomy was performed to remove the mass completely.
An incision into the removed specimen disclosed a
round mass of 1.5 cm diameter consisting of spleen-
like tissue completely surrounded by pancreatic
tissue (Fig. 2). Frozen sections confirmed the pres-
ence of an accessory spleen within the pancreatic
tail. The postoperative course was uneventful with
the exception of intestinal pseudoobstruction, which
was successfully treated by endoscopic decompres-
sion. The patient was discharged on the 17th post-
operative day in good health.
Pathological Findings
Pathological gross findings revealed a sharply
delineated and encapsulated tumor of up to 1.5 cm
in diameter, completely surrounded by lobular pan-
creatic tissue. There was no direct connection
between this tumor and the resected spleen. In par-
ticular, the splenic hilum was normal, and there was
no visible aberrant splenic artery. On sections, the
tissue of this intrapancreatic tumor was dark red with
numerous tiny gray dots. Histological examination
Fig. 1. CT scan of an accessory spleen in the pancreas
(arrow) mimicking distal pancreatic neoplasm with
homogeneous contrast enhancement. The hypervascular
enhancing mass appears to be extrapancreatic and
surrounded by fat in the posterior half of the lesion.
Fig. 2. Gross inspection of the resected specimen dis-
closed a round mass with a dark-red surface and a clear
margin in the pancreatic tail. The suspicion of an acces-
sory spleen was confirmed by microscopic examination.
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of this tumor mass showed the typical structure of
splenic tissue with well-developed red and white
pulp. A vascular hilum could not be detected, and
blood supply consisted of small to medium-sized
arteries and veins located within the capsule, an
angiologic architecture typical of an accessory
spleen. In the adjacent pancreatic tissue, adipocytes
were increased with a clustering of islets around the
accessory spleen’s capsule, whereas the exocrine
pancreatic tissue was poorly developed in this region
(Fig. 3).
Discussion
Accessory spleens are characterized by a lack of
vascular communication with the main spleen, a
missing hilum, and a blood supply through small
arteries within the capsule. They are usually located
in the region of the splenic hilum, but in about 16%
of cases in autopsy series, the accessory spleen is
located within the pancreatic tail (2). Particularly
high rates of accessory spleens within the pancreas
are found in individuals with trisomy 13, where
it is one of the distinctive features of this very rare,
but lethal genomic aberration (3). In adult patients,
accessory spleens within the pancreas are rarely
detected owing to their asymptomatic nature. How-
ever, their clinical importance resides in the mim-
icry of pancreatic cancer, which has an increasing
incidence in the Western World (4). The specificity
of CT scan for pancreatic cancer is rarely better than
80%, and even the combination of CT and ERCP
does not allow definition or exclusion of malignancy
in about 10% of patients (5). The value of newer
techniques, such as magnetic resonance imaging
(MRI), has still not been clearly defined, but a
prospective comparison of CT and MRI demon-
strated that MRI was superior to CT at identifying
small tumors (6). However, data determining the
accuracy of MRI in differential diagnosis of pan-
creatic tumors are still lacking. Thus, correct inter-
pretation of a pancreatic mass represents a clinical
challenge for the surgeon, especially in asympto-
matic individuals.
In our patient, abdominal CT scans revealed the
presence of a distal pancreatic mass, and the tumor
markers CA 19-9 and CEA were slightly elevated.
In contrast, ERCP was normal, and determination
of the gastrointestinal hormones failed to demon-
strate any alterations that would have raised suspi-
cion of the presence of an endocrine tumor of the
pancreas. In this unclear situation, we omitted fur-
ther diagnostic tests, such as MRI, angiography, and
scintigraphy, and performed a surgical exploration
with subsequent histopathological examination,
which enabled accurate diagnosis. In experienced
centers, surgical resection can be performed with an
acceptably low risk (7). However, in this patient, a
different diagnostic approach may have prevented
an operation.
In retrospect, we propose the following diagnos-
tic and therapeutic management: a nonenhancing
mass that is hypervascular should for the most part
be regarded as an adenocarcinoma of the pancreas
until proven otherwise. In such instances, a fine-
needle biopsy may be considered if surgery is pre-
cluded by clinical criteria. On the other hand, the
diagnosis of hypervascular enhancing mass raises the
possibility of a neuroendocrine tumor, a hypervas-
cular metastasis or an ectopic spleen. A careful eval-
uation of other organ systems should provide an
indication regarding the nature of any synchronous
primary neoplastic disease. A neuroendocrine tumor
may be investigated using an octreotide scan, which
is accurate in up to 90% of instances, except in the
case of insulinoma (8). Under such circumstances,
clinical symptomatology should allow for obvious
diagnosis. If the possibility of an ectopic spleen, which
is an extremely rare condition, is considered, a Tc99m-
sulfur-colloid scan should provide an appropriate
Fig. 3. Peripheral parts of the accessory spleen. Note
that the splenic capsule contains small arterial branches,
which are typical for this lesion. Adjacent to the capsule,
there are a few pancreatic islets (hematoxylin and eosin
staining, ×60).
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diagnosis (9). In the unlikely event of all such tests
producing equivocal results, it may well then be nec-
essary to consider a diagnostic laparoscopy or laparo-
tomy to follow if a tissue diagnosis is necessary.
Consideration of the patient’s fitness for anesthesia
and general surgery would obviously dictate the deter-
mination of therapy under these circumstances. An
important note of clinical caution is the fact that
the identification of hypervascular masses in the pan-
creas should be regarded as an indication for nonin-
vasive study either by radioisotopic imaging
techniques or, alternatively, by the use of angiography.
Fine-needle aspiration under such circumstances is
not warranted and potentially dangerous.
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